Daniel Grosslight
Stock Analyst at Citi
(3.30)
# 2,328
Out of 4,634 analysts
384
Total ratings
46.5%
Success rate
3.3%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Maintained: Hold | $35 → $33 | $31.77 | +3.87% | 51 | Aug 11, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,000 | $879.87 | +13.65% | 17 | Aug 10, 2026 | |
| ACH Accendra Health | Downgraded: Hold | $4.5 → $1.5 | $1.40 | +7.14% | 26 | Aug 10, 2026 | |
| ZTS Zoetis | Reiterated: Buy | $112 → $96 | $74.83 | +28.29% | 3 | Aug 10, 2026 | |
| EVH Evolent Health | Upgraded: Buy | $6.75 → $6 | $3.93 | +52.67% | 13 | Aug 10, 2026 | |
| HCAT Health Catalyst | Reiterated: Hold | $2.5 → $2 | $1.72 | +16.28% | 20 | Aug 10, 2026 | |
| NVST Envista Holdings | Reiterated: Hold | $29 → $32 | $28.19 | +13.52% | 2 | Aug 10, 2026 | |
| CTEV Claritev | Maintained: Buy | $40 → $45 | $34.07 | +32.08% | 24 | Aug 10, 2026 | |
| GDRX GoodRx Holdings | Rated: Buy | $4 → $5 | $3.66 | +36.61% | 31 | Aug 10, 2026 | |
| AGL agilon health | Upgraded: Hold | $105 → $115 | $96.78 | +18.83% | 12 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $22.37 | +56.46% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 → $370 | $325.00 | +13.85% | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $34 | $22.28 | +52.60% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $330 | $354.54 | -6.92% | 1 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $112 | $88.08 | +27.16% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $650 → $670 | $595.76 | +12.46% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $33.81 | +33.10% | 1 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 | $176.04 | +36.33% | 3 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $7.5 | $7.08 | +5.93% | 40 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $24.70 | +13.36% | 10 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $265 | $237.18 | +11.73% | 20 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $12.65 | +34.39% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $12 | $12.44 | -3.54% | 24 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $62 → $44 | $34.15 | +28.84% | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $11 | $11.66 | -9.95% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.90 | n/a | 1 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.25 → $1.75 | $0.6991 | n/a | 10 | Sep 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $19 → $8 | $13.54 | n/a | 9 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $1.26 | n/a | 14 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $11 | $0.0001 | n/a | 6 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $5.24 | n/a | 8 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.15 → $0.45 | $0.000001 | n/a | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $5.22 | n/a | 1 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $27.85 | n/a | 1 | Nov 19, 2019 |
Hims & Hers Health
Aug 11, 2026
Maintained: Hold
Price Target: $35 → $33
Current: $31.77
Upside: +3.87%
McKesson
Aug 10, 2026
Reiterated: Buy
Price Target: $1,000
Current: $879.87
Upside: +13.65%
Accendra Health
Aug 10, 2026
Downgraded: Hold
Price Target: $4.5 → $1.5
Current: $1.40
Upside: +7.14%
Zoetis
Aug 10, 2026
Reiterated: Buy
Price Target: $112 → $96
Current: $74.83
Upside: +28.29%
Evolent Health
Aug 10, 2026
Upgraded: Buy
Price Target: $6.75 → $6
Current: $3.93
Upside: +52.67%
Health Catalyst
Aug 10, 2026
Reiterated: Hold
Price Target: $2.5 → $2
Current: $1.72
Upside: +16.28%
Envista Holdings
Aug 10, 2026
Reiterated: Hold
Price Target: $29 → $32
Current: $28.19
Upside: +13.52%
Claritev
Aug 10, 2026
Maintained: Buy
Price Target: $40 → $45
Current: $34.07
Upside: +32.08%
GoodRx Holdings
Aug 10, 2026
Rated: Buy
Price Target: $4 → $5
Current: $3.66
Upside: +36.61%
agilon health
Aug 10, 2026
Upgraded: Hold
Price Target: $105 → $115
Current: $96.78
Upside: +18.83%
Aug 10, 2026
Reiterated: Buy
Price Target: $35
Current: $22.37
Upside: +56.46%
Aug 6, 2026
Maintained: Buy
Price Target: $355 → $370
Current: $325.00
Upside: +13.85%
Aug 6, 2026
Maintained: Buy
Price Target: $31 → $34
Current: $22.28
Upside: +52.60%
Aug 5, 2026
Maintained: Hold
Price Target: $330
Current: $354.54
Upside: -6.92%
Aug 5, 2026
Maintained: Buy
Price Target: $100 → $112
Current: $88.08
Upside: +27.16%
Aug 5, 2026
Maintained: Hold
Price Target: $650 → $670
Current: $595.76
Upside: +12.46%
Aug 5, 2026
Maintained: Buy
Price Target: $45
Current: $33.81
Upside: +33.10%
Aug 3, 2026
Reiterated: Buy
Price Target: $240
Current: $176.04
Upside: +36.33%
Aug 3, 2026
Maintained: Hold
Price Target: $11 → $7.5
Current: $7.08
Upside: +5.93%
Aug 3, 2026
Maintained: Buy
Price Target: $28
Current: $24.70
Upside: +13.36%
Jul 24, 2026
Maintained: Buy
Price Target: $245 → $265
Current: $237.18
Upside: +11.73%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $12.65
Upside: +34.39%
May 28, 2026
Reiterated: Hold
Price Target: $10 → $12
Current: $12.44
Upside: -3.54%
May 14, 2026
Rated: Hold
Price Target: $62 → $44
Current: $34.15
Upside: +28.84%
May 6, 2026
Maintained: Sell
Price Target: $10 → $11
Current: $11.66
Upside: -9.95%
May 29, 2024
Maintained: Buy
Price Target: n/a
Current: $24.90
Upside: n/a
Sep 14, 2023
Maintained: Hold
Price Target: $1.25 → $1.75
Current: $0.6991
Upside: n/a
Aug 4, 2023
Downgraded: Sell
Price Target: $19 → $8
Current: $13.54
Upside: n/a
May 18, 2023
Maintained: Hold
Price Target: $7 → $9
Current: $1.26
Upside: n/a
Mar 9, 2023
Maintained: Hold
Price Target: $15 → $11
Current: $0.0001
Upside: n/a
Mar 1, 2023
Maintained: Hold
Price Target: $1
Current: $5.24
Upside: n/a
Nov 15, 2022
Maintained: Hold
Price Target: $1.15 → $0.45
Current: $0.000001
Upside: n/a
Dec 11, 2019
Initiated Coverage: Buy
Price Target: $13
Current: $5.22
Upside: n/a
Nov 19, 2019
Initiated Coverage: Buy
Price Target: $28
Current: $27.85
Upside: n/a